Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
244
NCT01047891
Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2010
Completion: Feb 28, 2015
NCT01600573
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
Phase: Phase 1/2
Start: May 31, 2012
Completion: Mar 31, 2017
NCT01815528
Feasibility and Clinical Activity of Initial Intraperitoneal Catumaxomab Followed by Chemotherapy in Patients With Recurrent Ovarian Cancer
Start: Mar 31, 2013
Completion: Feb 28, 2014